ResearcherSichuan Academy of Medical Sciences & Sichuan Provincial People's HospitalActive in the last 2 years
Zhixi Li
Matched on ORCID iD 0000-0002-8686-6002; OpenAlex author ID A5101764802.
Their work
Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.
- Pancreatic cancer papers
- 3 (first author 1, last author 0)
- Pancreatic cancer trials
- 0
- Pancreatic cancer grants
- 0
- Collaborators
- 6
2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 1 paper
Papers 3
- ITGB6 may promote proliferation and invasion in pancreatic cancer. Co-author DOI 10.5114/aoms/114039↗
- HOXB5 promotes malignant progression in pancreatic cancer via the miR-6732 pathway. First author DOI 10.1080/15384101.2019.1707456↗
- miRNA-101 Suppresses Epithelial-to-Mesenchymal Transition by Targeting HMGA2 in Pancreatic Cancer Cells. Co-author DOI 10.2174/1871520615666150507122142↗
Closest collaborators
The 6 strongest of 6 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
- Qing Zhou · 1 shared paper, 2024
- Chao Zhong · 1 shared paper, 2024
- Yan-Tao Yin · 1 shared paper, 2020
- Xiaogeng Deng · 1 shared paper, 2016
- Qiaoming Zhi · 1 shared paper, 2016
- Wenli Jiang · 1 shared paper, 2016
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.